1-3 of 3
Teresa Melo, MD
Close
Sort by
Journal Articles

Functional Characterization of T- and NK-Cells in Chronic Myeloid Leukemia Patients Treated with Interferon-α Monotherapy.

Mette Matilda Ilander, MSc, Anna Kreutzman, PhD, Peter Rohon, MD, Teresa Melo, MD, Edgar Faber, MD, PhD, Kimmo Porkka, MD, PhD, Jukka Vakkila, MD, PhD, Satu Mustjoki, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 2782.
https://doi.org/10.1182/blood.V120.21.2782.2782
Published: 2012
Journal Articles

Dasatinib Induces a Rapid, Dose-Controllable Mobilization of Cytotoxic Lymphocytes: A Novel Immunomodulatory Effect Associated with Prolonged Therapy Responses In Advanced Leukemia.

Satu Mustjoki, MD, PhD, Philippe Rousselot, MD, PhD, Sari Jalkanen, Msc, Anna Kreutzman, MSc, Teresa Melo, MD, Anna-Maria Lahesmaa, MSc, Sampsa Hautaniemi, PhD, Mathieu Molimard, MD, PhD, Richard Smykla, PhD, Francis Lee, PhD, Jukka Vakkila, MD, PhD, Kimmo Porkka, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 1204.
https://doi.org/10.1182/blood.V116.21.1204.1204
Published: 2010
Journal Articles

Acute Myeloid Leukemia with Normal Karyotype: Analysis of FLT3, NPM1, MLL and CEBPA Gene Abnormalities.

Fernanda Trigo, MD, Fatima Torres, PharmD, Patricia Guimaraes, MD, Pedro Silva-Coelho, MD, Ines Carvalhais, MD, Ana Espirito Santo, MD, Teresa Melo, MD, Miriam Castro, MD, Alexandra Fernandes, PhD, Purificacao Tavares, MD, PhD, Jose E. Guimaraes, MD, PhD
Journal: Blood
Blood (2007) 110 (11): 4245.
https://doi.org/10.1182/blood.V110.11.4245.4245
Published: 2007